PSQ Holdings, Inc. quarterly report, Q2 FY2023

PSQ Holdings, Inc. — Q2 2023 Form 10-Q

Reporting period: Quarter and six months ended June 30, 2023. At that date, the registrant was still Colombier Acquisition Corp., a blank-check company; the figures below do not include PublicSq.’s operating results. The merger closed July 19, 2023, and the company changed its name to PSQ Holdings, Inc.

Financial results and liquidity

MetricQ2 2023Q2 2022Six months 2023Six months 2022
Operating revenueNoneNoneNoneNone
Operating and formation costs$2.83 million$0.25 million$4.38 million$0.54 million
Interest earned on Trust Account securities$2.04 million$0.23 million$3.88 million$0.24 million
Change in warrant-liability fair value$(6.30) million$1.98 million$(7.79) million$4.85 million
Net income (loss)$(7.62) million$1.94 million$(9.28) million$4.53 million
Basic and diluted loss per share$(0.35)$0.09 income$(0.43)$0.21 income

Profitability and margins are not meaningful for this pre-combination blank-check period because the company generated no operating revenue. The quarterly and year-to-date losses were materially affected by non-cash warrant remeasurement.

  • Cash and liquidity: Cash outside the Trust Account was $1.20 million at June 30, versus $0.20 million at December 31, 2022. The company reported a working-capital deficit of $2.10 million.
  • Trust assets: Marketable securities in the Trust Account were $175.88 million at June 30, including accrued investment returns. In July, substantially all Trust funds were used to complete the business combination and fund redemptions; the June balance is not a measure of post-close cash available to the combined company.
  • Cash flow: Operating activities used $1.95 million in the first half of 2023, compared with $0.56 million in the prior-year period. Trust withdrawals of $2.95 million for working capital and taxes contributed to the $1.01 million increase in cash.
  • Liabilities and debt: Total liabilities were $19.26 million, including $8.82 million of warrant liabilities, $6.04 million of deferred underwriting fees, and $4.41 million of current liabilities. The company reported no long-term debt; the filing says no related-party loans were outstanding.

Material changes and notable events

  • Q2 2023 shifted from prior-year net income to a net loss, as operating and formation costs rose and warrant fair-value changes moved from income to expense. The warrant liability increased to $8.82 million from $1.03 million at year-end 2022.
  • Before the July 19 closing, holders requested redemption of 14,286,259 public shares, approximately 83% of Colombier’s pre-redemption public shares; 2,963,741 public shares remained afterward.
  • The company stated that completion of the business combination alleviated the going-concern doubt identified before closing. Its prior deadline to complete a transaction or liquidate was September 11, 2023.

Outlook, risks, and controls

  • The filing provides no quantified operating guidance or forecast. Management said it did not expect operating revenue before completion of the business combination; the post-close operating outlook is not provided in this report.
  • Potential risks discussed include market and geopolitical uncertainty and possible application of the federal 1% excise tax to certain share repurchases or redemptions. The tax’s applicability and amount were uncertain.
  • Management concluded disclosure controls and procedures were ineffective because of a material weakness in internal control over financial reporting related to accounting for complex financial instruments. Planned remediation included improving review procedures, access to accounting expertise, and staff resources.
  • The company reported no legal proceedings and no off-balance-sheet arrangements as of June 30, 2023. Interim results are not necessarily indicative of future results.

Important facts for investors to verify

  • Post-combination cash, debt, liquidity needs, and the effects of the 83% public-share redemption; the June 30 Trust Account balance was largely deployed at closing.
  • Combined-company operating results and guidance, which are not reflected in this pre-combination 10-Q.
  • Whether the accounting-control material weakness has been remediated and whether it affects subsequent filings.
  • Final treatment of deferred underwriting fees and any potential excise-tax liability associated with the redemptions.